When it comes to losing weight, pills and injections have become a big part of the conversation. But not all weight loss medications are created equal. Two major groups dominate today’s options: the newer GLP-1 agonists and the older, more familiar drugs that have been around for decades. If you’re trying to decide which path makes sense for you, understanding the real differences - not just the marketing - is critical.
How GLP-1 Agonists Actually Work
GLP-1 agonists like Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) don’t just suppress your appetite. They mimic a natural hormone your body already makes called glucagon-like peptide-1. This hormone tells your brain when you’re full, slows down how fast food leaves your stomach, and helps your pancreas release insulin when needed. The result? You feel full sooner, eat less, and your blood sugar stays more stable.
These drugs were originally designed for type 2 diabetes. But in clinical trials, people lost far more weight than expected. Wegovy, for example, led to an average of 14.7% body weight loss in 36 weeks. Zepbound, which also targets a second hormone (GIP), showed even more - up to 20.9% over 72 weeks. That’s not just a few pounds. That’s a major shift in body composition.
Most GLP-1 agonists are injected once a week. Liraglutide (Saxenda) is the exception - it’s daily. There’s also an oral version of semaglutide called Rybelsus, but it’s only approved for diabetes, not weight loss. The injection route means you need to get comfortable with needles, but for many, the results outweigh the discomfort.
Older Weight Loss Drugs: What’s Still Out There
Before GLP-1 agonists took center stage, the market was filled with drugs like orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), and naltrexone-bupropion (Contrave). These work in completely different ways.
Orlistat blocks fat absorption in your gut. About 30% of the fat you eat passes through undigested. That means greasy stools, frequent bathroom trips, and the need to take it with every meal. It’s not glamorous, and it doesn’t work for everyone.
Phentermine-topiramate (Qsymia) combines a stimulant (phentermine) with an anti-seizure drug (topiramate) that also reduces appetite. It can help people lose around 10% of their body weight. But it comes with risks - increased heart rate, tingling in hands and feet, and potential birth defects if taken during pregnancy.
Naltrexone-bupropion (Contrave) targets the brain’s reward system. It’s meant to reduce cravings and make food feel less rewarding. Studies show about 5-8% weight loss on average. It’s generally well-tolerated, but people with uncontrolled high blood pressure or seizure disorders shouldn’t take it.
All of these older drugs are taken as pills. No needles. No injections. That’s a big plus for people who hate needles or can’t manage daily injections.
Efficacy: The Numbers Don’t Lie
Let’s cut through the noise. When you compare head-to-head, GLP-1 agonists win by a wide margin.
A direct study cited by GoodRx found that Wegovy led to 16% weight loss, while Saxenda - another GLP-1 drug - only achieved 6%. That’s more than double the effect. Even compared to the best of the older drugs, GLP-1s are in another league.
Here’s a quick snapshot of average weight loss in clinical trials:
| Medication | Typical Weight Loss | Duration |
|---|---|---|
| Wegovy (semaglutide) | 14.7% - 16% | 36-72 weeks |
| Zepbound (tirzepatide) | 18% - 20.9% | 72 weeks |
| Saxenda (liraglutide) | 6% - 8% | 56 weeks |
| Qsymia (phentermine-topiramate) | 8% - 10% | 56 weeks |
| Contrave (naltrexone-bupropion) | 5% - 8% | 56 weeks |
| Orlistat (Xenical) | 5% - 10% | 12 months |
Real-world results are lower than trial numbers. A study from NYU Langone Health found that after six months, people on GLP-1 drugs lost only 4.7% on average. After a year, it was 7%. That’s still more than most older drugs, but it shows that sticking with treatment is harder than it sounds.
Cost: The Biggest Hurdle
Price is where the gap becomes a chasm.
GLP-1 agonists cost between $1,000 and $1,400 per month without insurance. That’s $12,000 to $16,800 a year. Even with manufacturer coupons, you’re still looking at $500-$1,000 in out-of-pocket costs annually. Many insurance plans only cover them if you have type 2 diabetes or a BMI over 40 - or over 35 with another health condition like high blood pressure or sleep apnea.
Older drugs? Not even close. Phentermine can cost as little as $10-$50 a month. Orlistat (Alli) is available over-the-counter for around $30-$60. Qsymia and Contrave are pricier, but still usually under $150 a month with insurance.
According to a KFF Health Tracking Poll in May 2024, 62% of people using GLP-1 drugs say they struggle to afford them. And 45% report being denied coverage outright because of strict insurance rules.
Side Effects: What You Might Not Be Prepared For
GLP-1 agonists aren’t magic. Nausea, vomiting, diarrhea, and constipation are common - especially when you’re starting or increasing your dose. Up to 50% of users experience these during the first few months. Some report severe bloating, gastroparesis (delayed stomach emptying), or even gallbladder problems.
Older drugs have side effects too. Orlistat causes oily stools and frequent bowel movements. Phentermine can raise heart rate and blood pressure. Contrave may cause headaches and dizziness. But none of them carry the same level of gastrointestinal disruption as GLP-1s.
Reddit communities like r/Wegovy and r/Ozempic are full of stories. Some users celebrate losing 78 pounds. Others describe months of nausea so bad they had to stop. One person wrote, "I lost 45 pounds, but I felt like I was constantly sick." That’s not uncommon.
Long-Term Use and Discontinuation
Here’s the hard truth: if you stop taking a GLP-1 agonist, you’ll likely regain most of the weight. Studies show 50% to 100% of lost weight comes back within a year of stopping.
That’s why many experts say these drugs aren’t a cure - they’re a tool. You need to combine them with lifestyle changes: better food choices, regular movement, stress management. Otherwise, the scale will climb back up.
And many people stop. A study in JAMA Surgery found up to 70% of patients discontinue GLP-1 therapy within a year. Reasons? Cost, side effects, or simply not losing enough.
Who Should Consider Which Option?
Here’s a simple guide:
- Choose a GLP-1 agonist if: You want the most significant weight loss possible, you’re okay with weekly injections, you can afford the cost or have good insurance, and you’re willing to stick with it long-term. These are especially helpful if you also have type 2 diabetes.
- Choose an older drug if: You can’t afford GLP-1s, hate needles, have insurance that won’t cover newer drugs, or need something with fewer GI side effects. Phentermine or orlistat might be a better starting point.
There’s no one-size-fits-all. Some people start with an older drug to see how their body responds. Others go straight to GLP-1s if their doctor believes they’re a strong candidate.
What’s Next? The Future of Weight Loss Drugs
The pipeline is full. Retatrutide, a triple-agonist targeting GLP-1, GIP, and glucagon, showed 24.2% weight loss in early trials. MariTide, a new antibody from Amgen, is now in Phase 3 testing. These could be even more effective.
But cost and access will remain issues. Right now, only 28% of commercial insurance plans cover GLP-1s for weight loss without strict restrictions. Until that changes, these drugs will remain out of reach for most.
And while surgery - like gastric bypass - still leads to 24% weight loss over two years, it’s invasive and not for everyone. GLP-1s offer a non-surgical alternative. But they’re not a replacement for surgery. They’re another tool in a bigger toolbox.
The bottom line? GLP-1 agonists are the most powerful weight loss drugs we’ve ever had. But they’re not simple. They’re expensive. They have real side effects. And they don’t work unless you keep taking them.
If you’re considering one, talk to your doctor. Ask about your insurance coverage. Ask about alternatives. Ask what happens if you stop. And be honest with yourself: Can you handle the cost? The injections? The nausea? The long-term commitment?
Because this isn’t about finding the "best" drug. It’s about finding the right one - for your body, your budget, and your life.
Are GLP-1 agonists better than bariatric surgery?
No - not for everyone. Bariatric surgery typically leads to 24% total body weight loss over two years, compared to 7% after one year with GLP-1 drugs in real-world settings. Surgery is more effective and durable, especially for people with severe obesity. But it’s invasive, has its own risks, and requires major lifestyle changes. GLP-1s offer a non-surgical option for those who can’t or won’t have surgery, but they’re not a substitute.
Can I take GLP-1 agonists if I don’t have diabetes?
Yes. Wegovy and Zepbound are FDA-approved specifically for chronic weight management in adults with obesity or overweight, even without diabetes. However, insurance coverage often requires a diagnosis of obesity (BMI ≥30) or overweight with at least one weight-related condition like high blood pressure, sleep apnea, or high cholesterol.
Why do GLP-1 drugs cause nausea?
GLP-1 agonists slow down gastric emptying - meaning food stays in your stomach longer. This helps you feel full, but it can also cause bloating, nausea, and vomiting, especially when starting or increasing the dose. Most side effects improve over time as your body adjusts. Doctors recommend starting at the lowest dose and increasing slowly to reduce these effects.
Do GLP-1 agonists work for everyone?
No. Studies show about 30% of users don’t lose enough weight to justify continuing. Others stop due to side effects or cost. People with certain gut conditions, like severe gastroparesis, may not be good candidates. Genetics, metabolism, and lifestyle all play a role in how well these drugs work.
Is it safe to use GLP-1 agonists long-term?
Current data suggests they’re safe for long-term use. Semaglutide was shown to reduce heart attack and stroke risk in high-risk patients in the SELECT trial. But long-term data beyond five years is still limited. Regular check-ups with your doctor - including monitoring kidney function, thyroid health, and nutritional status - are essential.
Can I switch from an older weight loss drug to a GLP-1 agonist?
Yes, but it requires medical supervision. You can’t just stop one and start another. Your doctor will need to consider how your body responded to the old drug, whether you have any contraindications, and how to manage the transition safely - especially to avoid worsening side effects like nausea or low blood sugar.
Stephanie Paluch
March 13, 2026 AT 12:05tynece roberts
March 14, 2026 AT 18:51Hugh Breen
March 15, 2026 AT 16:37Rex Regum
March 16, 2026 AT 16:40Noluthando Devour Mamabolo
March 18, 2026 AT 06:29Tim Schulz
March 18, 2026 AT 13:38Aaron Leib
March 19, 2026 AT 21:13Lorna Brown
March 20, 2026 AT 14:30Rosemary Chude-Sokei
March 21, 2026 AT 02:51tamilan Nadar
March 22, 2026 AT 20:39Emma Deasy
March 23, 2026 AT 11:37Sally Lloyd
March 25, 2026 AT 02:12Kandace Bennett
March 25, 2026 AT 20:10Byron Boror
March 27, 2026 AT 16:34Leah Dobbin
March 28, 2026 AT 02:14Stephanie Paluch
March 29, 2026 AT 07:14